Cargando…
Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness
As the current coronavirus pandemic continues and cases of COVID-19 critical illness rise, physicians and scientists across the globe are working to understand and study its pathophysiology. Part of the pathology of this illness may result from its prothrombotic potential as witnessed from derangeme...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832361/ https://www.ncbi.nlm.nih.gov/pubmed/32829961 http://dx.doi.org/10.1016/j.blre.2020.100731 |
_version_ | 1783641820730753024 |
---|---|
author | Mir, Nabiel D'Amico, Alex Dasher, John Tolwani, Ashita Valentine, Vincent |
author_facet | Mir, Nabiel D'Amico, Alex Dasher, John Tolwani, Ashita Valentine, Vincent |
author_sort | Mir, Nabiel |
collection | PubMed |
description | As the current coronavirus pandemic continues and cases of COVID-19 critical illness rise, physicians and scientists across the globe are working to understand and study its pathophysiology. Part of the pathology of this illness may result from its prothrombotic potential as witnessed from derangements in coagulation and thrombotic complications reported in observational studies performed in China and Europe to findings of microthrombosis upon autopsy analysis of patients who succumbed to COVID-19. Multiple organizations, including the American Society of Hematology (ASH), recommend the routine use of prophylactic heparin to temper the thrombotic complications of this illness given its mortality benefit in severe COVID-19 infections. Reductions in circulating levels of Antithrombin III (AT), the primary mediator of heparin's action, is present in cases of coronavirus related critical illness. AT's use as a prognostic marker, an important effector of heparin resistance, and a potential therapeutic target for COVID-19 remains to be explored. |
format | Online Article Text |
id | pubmed-7832361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78323612021-01-26 Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness Mir, Nabiel D'Amico, Alex Dasher, John Tolwani, Ashita Valentine, Vincent Blood Rev Review As the current coronavirus pandemic continues and cases of COVID-19 critical illness rise, physicians and scientists across the globe are working to understand and study its pathophysiology. Part of the pathology of this illness may result from its prothrombotic potential as witnessed from derangements in coagulation and thrombotic complications reported in observational studies performed in China and Europe to findings of microthrombosis upon autopsy analysis of patients who succumbed to COVID-19. Multiple organizations, including the American Society of Hematology (ASH), recommend the routine use of prophylactic heparin to temper the thrombotic complications of this illness given its mortality benefit in severe COVID-19 infections. Reductions in circulating levels of Antithrombin III (AT), the primary mediator of heparin's action, is present in cases of coronavirus related critical illness. AT's use as a prognostic marker, an important effector of heparin resistance, and a potential therapeutic target for COVID-19 remains to be explored. Elsevier Ltd. 2021-01 2020-07-03 /pmc/articles/PMC7832361/ /pubmed/32829961 http://dx.doi.org/10.1016/j.blre.2020.100731 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Mir, Nabiel D'Amico, Alex Dasher, John Tolwani, Ashita Valentine, Vincent Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness |
title | Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness |
title_full | Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness |
title_fullStr | Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness |
title_full_unstemmed | Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness |
title_short | Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness |
title_sort | understanding the andromeda strain – the role of cytokine release, coagulopathy and antithrombin iii in sars-cov2 critical illness |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832361/ https://www.ncbi.nlm.nih.gov/pubmed/32829961 http://dx.doi.org/10.1016/j.blre.2020.100731 |
work_keys_str_mv | AT mirnabiel understandingtheandromedastraintheroleofcytokinereleasecoagulopathyandantithrombiniiiinsarscov2criticalillness AT damicoalex understandingtheandromedastraintheroleofcytokinereleasecoagulopathyandantithrombiniiiinsarscov2criticalillness AT dasherjohn understandingtheandromedastraintheroleofcytokinereleasecoagulopathyandantithrombiniiiinsarscov2criticalillness AT tolwaniashita understandingtheandromedastraintheroleofcytokinereleasecoagulopathyandantithrombiniiiinsarscov2criticalillness AT valentinevincent understandingtheandromedastraintheroleofcytokinereleasecoagulopathyandantithrombiniiiinsarscov2criticalillness |